Skip to search formSkip to main contentSkip to account menu

BID protein

Known as: BH3 Interacting Domain Death Agonist Protein [Chemical/Ingredient], BID, BH3 Interacting Domain Death Agonist Protein 
BH3-interacting domain death agonist (195 aa, ~22 kDa) is encoded by the human BID gene. This protein plays a role in the promotion of apoptosis.
National Institutes of Health

Related topics

Related topics

23 relations
Alzheimer's Disease Pathway KEGGApoptosisApoptosis PromoterBH3 Domain

Narrower (1)

tBid Protein

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
An Interconnected Hierarchical Model of Cell Death Regulation by the BCL-2 Family
Multidomain pro-apoptotic BAX and BAK, once activated, permeabilize mitochondria to trigger apoptosis, whereas anti-apoptotic BCL… 
Review
2011
Review
2011
An overview of once‐weekly glucagon‐like peptide‐1 receptor agonists—available efficacy and safety data and perspectives for the future
Incretin‐based therapies, such as the injectable glucagon‐like peptide‐1 (GLP‐1) receptor agonists and orally administered… 
Review
2010
Review
2010
Lysosomal-mitochondrial cross-talk during cell death.
Highly Cited
2005
Highly Cited
2005
Laryngopharyngeal Reflux: Prospective Cohort Study Evaluating Optimal Dose of Proton‐Pump Inhibitor Therapy and Pretherapy Predictors of Response
Purpose: Laryngopharyngeal reflux (LPR) is frequently treated with empiric proton‐pump inhibitors (PPI), but the optimal dosing… 
Highly Cited
2004
Highly Cited
2004
SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients
Objective: To compare the magnitude and durability of the antiviral response to fosamprenavir (FPV) plus ritonavir (RTV) once… 
Highly Cited
2004
Highly Cited
2004
The NEAT Study: A 48-Week Open-Label Study to Compare the Antiviral Efficacy and Safety of GW433908 Versus Nelfinavir in Antiretroviral Therapy–Naive HIV-1-Infected Patients
ObjectiveTo compare the efficacy, durability, and tolerability of GW433908 (908), 1400 mg twice-daily (BID), with nelfinavir (NFV… 
Highly Cited
2003
Highly Cited
2003
Proapoptotic BID is required for myeloid homeostasis and tumor suppression.
The proper expansion and contraction of hematopoietic cells requires tight regulation of cell death. BID, a "BH3-only" molecule… 
Highly Cited
2002
Highly Cited
2002
Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis.
Highly Cited
1999
Highly Cited
1999
A Government for Our Time? Business Improvement Districts and Urban Governance
The emergence and rapid spread of business improvement districts ("BIDs") is one ofthe most important recent devehpments in… 
Highly Cited
1999
Highly Cited
1999
Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Vasodilator…
BACKGROUND ACE inhibitors may not adequately suppress deleterious levels of angiotensin II in patients with heart failure. An… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)